Xtrackers MSCI Europe UCITS ETF 1C (GBP) | XMEURegister to Unlock Ratings |
Performance History | 30/11/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.2 | 17.7 | -4.1 | 13.4 | 4.9 | |
+/-Cat | -2.1 | 2.3 | 4.2 | 1.8 | 2.4 | |
+/-B’mrk | -0.3 | 0.0 | 0.4 | 0.2 | -0.1 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 04/12/2024 | GBX 7563.00 | |
Day Change | 0.08% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 1981 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU0274209237 | |
Fund Size (Mil) 03/12/2024 | USD 4863.81 | |
Share Class Size (Mil) 03/12/2024 | USD 4489.44 | |
Ongoing Charge 09/09/2024 | 0.13% | |
*
This rating and report were issued for a different share class of this fund. The performance and fee structure of this class may vary from that referenced. |
Morningstar Research |
Investment Objective: Xtrackers MSCI Europe UCITS ETF 1C (GBP) | XMEU |
The aim is for your investment to reflect the performance of the MSCI Total Return Net Europe Index (the "Reference Index") which is designed to reflect the performance of the shares of certain companies in European developed markets. The companies making up the Reference Index are large and medium sized companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 10/01/2007 | ||
Inception Date 10/01/2007 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR USD | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Xtrackers MSCI Europe UCITS ETF 1C (GBP) | XMEU | 03/12/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 3.30 |
ASML Holding NV | Technology | 2.61 |
SAP SE | Technology | 2.37 |
Nestle SA | Consumer Defensive | 2.12 |
Novartis AG Registered Shares | Healthcare | 1.94 |
Increase Decrease New since last portfolio | ||
Xtrackers MSCI Europe UCITS ETF 1C (GBP) | XMEU |